Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JBIO compared with DMRA: revenue, margins and what each company keeps, and the suppliers and customers both name
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
DMRA
Damora Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
JBIO
Jade Biosciences, Inc.
vs
DMRA
Damora Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
JBIO
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±18.9%
▼
−1.05%
×0.06
May 8 '26
±24.6%
▲
+6.56%
×0.27
Q1 FY26
±29.2%
▲
+1.22%
×0.04
Jan 5 '26
±26.0%
▼
−7.34%
×0.28
DMRA
No earnings history for DMRA.
= implied
JBIO realized, solid
DMRA realized, hatched
One scale, both sides: full bar = 30%
× = |realized| ÷ implied
Source: market data
JBIO
Jade Biosciences, Inc.
Change
14.50
▲
+4.10%
Mkt cap
$885.9M
DMRA
Damora Therapeutics, Inc.
Change
21.90
▲
+1.37%
Regular session
Nov 3 '26
Mkt cap
$1.3B
vs
Compare
Regular session
Nov 3 '26
JBIO
Jade Biosciences, Inc.
vs
DMRA
Damora Therapeutics, Inc.
14.50
▲
+4.10%
Price
21.90
▲
+1.37%
$885.9M
Mkt cap
$1.3B
Change
Change
JBIO
14.50
▲
+4.10%
vs
DMRA
21.90
▲
+1.37%
Regular session
Nov 3 '26